SOUTH SAN FRANCISCO, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering…
SAM approval marks an important step in gaining entrée to the Department of Defense, Veterans Affairs and other government agenciesROSELAND,…
Strategic investment in CG Labs’ revenue generating and already profitable business increases NEXGEL’s capacity, improves margins and streamlines supply chain…
CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular…
AJ201 is being evaluated in a Phase 1b/2a clinical trial in the U.S. for the rare X-linked genetic neurodegenerative disease…
VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or…
Vaxxinity to present new preclinical data on anti-tau Alzheimer’s vaccine candidate VXX-301 at AD/PD International ConferenceCAPE CANAVERAL, Fla., March 02,…
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2023 at 15.00 EET Orion Corporation: Managers’ transactions – Jari Karlson Orion Corporation…
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2023 at 15.00 EET Orion Corporation: Managers’ transactions – Olli Huotari Orion Corporation…
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2023 at 15.00 EET Orion Corporation: Managers’ transactions – Satu Ahomäki Orion Corporation…